Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.
Medically reviewed by Min Clinic Staff | Updated: January 2026
Dosing and uses of Crisaborole topical
Atopic Dermatitis
Pending FDA approval for mild-to-moderate atopic dermatitis
Pharmacology of Crisaborole topical
Mechanism of action
Phosphodiesterase (PDE)-4 inhibitor; allows for cyclic adenosine monophosphate (cAMP) to remain intact in order to decrease the proinflammatory response (eg, cytokine release) associated with atopic dermatitis
